Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis — COAST_UAcCNV  

Chorioretinitis Clinical Trial

Official title: Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of antiangiogenic therapy to choroidal neovascularization secondary to central chorioretinitis.

Clinical Trial Description

The purpose of this study is to determine the effectiveness of antiangiogenic therapy to choroidal neovascularization secondary to central chorioretinitis. This study is planned as a follow-up. Patients with central chorioretinitis included in it will receive antiangiogenic therapy in accordance with the approved indications for use indicated in the instructions for the use of drugs in Ukraine. The treatment proposed in this study is based on the world experience and scientific developments of the Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine ". Therefore, it is expected that the benefit / risk ratio in relation to the participation in this study should not be different from that described in the scientific literature and the benefits outweigh the risk. It is known that the absence of treatment in these diseases leads to an irreparable loss of central vision. ;

Related Conditions & MeSH terms

• Chorioretinitis
• Choroidal Neovascularization
• Neovascularization, Pathologic

• NCT number: NCT04245072
• Study type: Interventional
• Source: The Filatov Institute of Eye Diseases and Tissue Therapy
• Contact: Andrii MD Korol, PhD
• Phone: +380936327266
• Email: andrii.r.korol@gmail.com
• Status: Recruiting
• Phase: N/A
• Start date: March 27, 2018
• Completion date: January 31, 2022